Skip to content
Home/Companies/Biotech/Noxxon

Noxxon

Biotech·France·Exited 2016·Held 9yr
Entry
2007
Hold
9yr
Exit
2016

Who owns Noxxon?

Noxxon is a French Biotech company, formerly owned by Andera Partners, exited in 2016 (exit via Trade Sale). No current private equity owner is on file.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 2 · 2007 · VC

Key facts

HQFrance
SectorBiotech
Exit Type
Trade Sale
Exit Year
2016

More from BioDiscovery 2

Other portfolio companies in the same fund.

SuperSonic Imagine
Exited 2019
MedTechFrance· 2008
to Hologic
Implanet
Implanet
Exited 2013
MedTechFrance· 2007
JenaValve
JenaValve
Exited 2024
MedTechFrance· 2007
to Edwards Lifesciences

More Andera Partners portfolio companies

From the same investor, across funds.

Artemys
Artemys
Exited 2025
TMTFrance
to SPIE Group (SPIE ICS)
Inotrem
Active
BiotechFrance
Alveus Therapeutics
Alveus Therapeutics
Active
BiotechFrance· 2026
Basis
Active
· 2026
exceet Card Group
Active
TMTFrance· 2026
Plasseraud IP
Active
France· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Noxxon?

Noxxon was formerly owned by Andera Partners, exited in 2016. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue